Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine

4-butyrolactone has been researched along with l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyama, T; Nakajima, M; Okuyama, A1

Reviews

1 review(s) available for 4-butyrolactone and l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine

ArticleYear
[CDK and MMP inhibitors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:11

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Colonic Neoplasms; Cyclin-Dependent Kinases; Dipeptides; Doxorubicin; Enzyme Inhibitors; Fibrosarcoma; Humans; Metalloendopeptidases; Mice; Mice, Nude; Protease Inhibitors; Succinates

1997